For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
5,000,000 - 5,000,000 [iU]
From 5,000,000 To 5,000,000 [iU] once every 2 day(s)
Adjunctively with chemotherapy, interferon alfa-2b may be administered subcutaneously, at a dose of 5 million IU three times a week (every other day) for a duration of 18 months. CHOP-like regimens are advised, but clinical experience is available only with CHVP (combination of cyclophosphamide, doxorubicin, teniposide and prednisolone).